Cochrane Abstracts
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma. Accessed April 18, 2025.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma
Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
ID - 431170
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
